western
immunoblot
assay
confirmatori
serodiagnosi
sever
acut
respiratori
syndrom
sar
develop
util
viral
lysat
antigen
combin
recombin
nucleocapsid
protein
gstn
glutathion
stransferasenucleocapsid
sar
coronaviru
sarscov
viral
lysat
antigen
separ
electrophoresi
transblot
onto
nitrocellulos
membran
result
membran
subsequ
ad
gstn
recombin
protein
specif
locat
posit
band
correspond
structur
protein
immobil
membran
locat
verifi
mous
rabbit
antisera
specif
respect
protein
western
immunoblot
assay
abl
detect
antibodi
sarscov
serum
specimen
sar
patient
differenti
sarsposit
sampl
healthi
donor
nonsar
patient
control
sampl
set
criteria
follow
addit
immunoblot
use
test
sampl
consid
fals
posit
inhousedevelop
sarsspecif
enzymelink
immunosorb
assay
band
pattern
differ
sampl
sar
patient
obtain
sever
acut
respiratori
syndrom
sar
seriou
respiratori
ill
famou
mortal
rate
caus
novel
coronaviru
sarscov
affect
patient
develop
symptom
atyp
pneumonia
earli
accur
differenti
sar
atyp
pneumonia
critic
success
manag
highli
contagi
diseas
outbreak
diagnosi
diseas
reli
clinic
symptom
also
travel
contact
histori
howev
postoutbreak
era
travel
contact
histori
less
signific
demonstr
recent
reemerg
case
guangdong
china
diagnosi
diseas
inevit
reli
heavili
laboratori
evid
henc
provid
tool
accur
laboratori
diagnosi
remain
prioriti
critic
futur
diseas
manag
although
variou
approach
protocol
avail
date
standard
test
laboratori
diagnosi
sar
http
wwwwhointcsrsarsconferencejun
recent
report
revers
transcriptionpcr
protocol
two
world
health
organ
sar
network
laboratori
evalu
find
studi
support
previou
suggest
exist
pcr
protocol
rule
presenc
sar
viru
neg
result
obtain
neither
protocol
exclud
possibl
fals
detect
due
laboratori
contamin
altern
approach
enzymelink
immunosorb
assay
elisa
rapid
immunochromatograph
test
also
develop
report
play
role
provid
diagnost
inform
complementari
provid
pcr
howev
confirmatori
test
verifi
result
gener
method
desir
may
essenti
western
immunoblot
assay
routin
use
confirmatori
test
last
decad
remain
import
tool
manag
viral
infect
caus
human
immunodefici
viru
human
tcell
lymphotrop
viru
hepat
c
viru
platform
may
similar
role
effort
diagnos
infect
sarscov
fact
recent
attempt
made
util
western
blot
platform
detect
antibodi
sarscov
patient
howev
effort
mostli
center
appli
singl
protein
marker
detect
thu
result
test
gave
limit
inform
similar
provid
elisa
immunofluoresc
antibodi
test
present
studi
extend
effort
develop
western
immunoblot
util
viral
lysat
antigen
combin
sarsspecif
recombin
protein
gstn
glutathion
stransferasenucleocapsid
new
test
provid
inform
antibodi
detect
also
protein
band
pattern
might
use
diagnost
prognost
purpos
serum
specimen
forti
serum
specimen
convalescentphas
patient
collect
consent
sar
patient
age
year
median
age
year
admit
tan
tock
seng
hospit
singapor
gener
hospit
fifti
sera
healthi
donor
purchas
bioclin
partner
inc
franklin
mass
also
includ
studi
control
nonsar
patient
control
archiv
genelab
diagnost
singapor
serum
sampl
previou
studi
use
sampl
obtain
prior
sar
outbreak
includ
sampl
patient
nonsarsrel
fever
confirm
dengu
fever
suffer
nonsarsrel
respiratori
ill
confirm
tuberculosi
addit
sampl
identifi
fals
posit
antibodi
sarscov
screen
healthi
donor
previou
studi
includ
present
studi
sampl
also
collect
healthi
donor
prior
outbreak
sar
purchas
bioclin
partner
inc
serum
sampl
store
use
sarscov
viral
lysat
recombin
protein
sarscov
viral
lysat
purchas
zeptometrix
corpor
buffalo
ny
obtain
sar
covinfect
vero
cell
sucros
gradient
purif
treatment
disrupt
buffer
kcl
contain
triton
four
recombin
protein
use
purpos
gener
proteinspecif
antisera
glutathion
stransferas
gst
fusion
protein
spike
gst
amino
acid
aa
nucleocapsid
gstn
aa
matrix
gstm
aa
envelop
gste
aa
protein
addit
gstn
protein
use
produc
western
immnuoblot
delet
highli
conserv
motif
aa
found
cov
materi
method
use
obtain
recombin
protein
describ
detail
previous
shen
et
al
unpublish
data
briefli
protein
express
gst
fusion
protein
escherichia
coli
gstn
purifi
gshsepharos
bead
amersham
pharmacia
biotech
uppsala
sweden
gst
gstm
gste
protein
separ
respect
insolubl
protein
pellet
carri
wash
resuspens
protein
eventu
electrophoresi
sodium
dodecyl
polyacrylamid
gel
electrophoresi
page
gel
gel
strip
contain
respect
gst
fusion
protein
cut
subject
elut
mini
transblot
cell
biorad
result
fusion
protein
detect
western
blot
antigst
monoclon
antibodi
santa
cruz
biotechnolog
santa
cruz
calif
concentr
estim
compar
bovin
serum
albumin
standard
coomassi
bluestain
page
gel
mous
rabbit
antisera
specif
antisera
rais
inocul
mice
rabbit
describ
previous
respect
recombin
protein
mous
antisera
specif
n
protein
gener
subcutan
inocul
balbc
mice
g
respect
recombin
protein
emulsifi
complet
freund
adjuv
sigma
st
loui
mo
rabbit
antiserum
specif
e
recombin
protein
gener
subcutan
inocul
new
zealand
white
rabbit
mg
purifi
protein
emulsifi
complet
freund
adjuv
anim
given
booster
dose
total
time
interv
booster
dose
contain
amount
respect
purifi
protein
emulsifi
incomplet
freund
adjuv
sigma
sera
immun
anim
harvest
day
last
immun
adsorb
mammalian
cell
cultur
reduc
nonspecif
bind
cellular
protein
separ
sarscov
viral
lysat
perform
separ
gel
stack
gel
particular
g
sarscov
viral
lysat
l
denatur
buffer
sd
tri
ph
glycerol
bromophenol
blue
track
dye
boil
min
water
bath
molecular
weight
determin
l
treat
lysat
sampl
rainbow
molecular
marker
amersham
pharmacia
appli
separ
well
width
sdspage
gel
immunoblot
analys
treat
sampl
l
appli
prepar
well
width
electrophores
constant
current
track
dye
reach
bottom
separ
protein
electrotransf
tank
apparatu
hoeffer
san
francisco
calif
nitrocellulos
membran
whatman
gerbershausen
germani
upon
complet
transblot
viral
lysat
antigen
membran
subsequ
ad
goat
antihuman
immunoglobulin
g
igg
g
per
membran
gstn
recombin
protein
ng
per
membran
two
separ
line
specif
locat
autoslot
machin
genelab
diagnost
goat
antihuman
igg
antibodi
ad
sampl
addit
control
purpos
confirm
neg
result
blank
strip
truli
neg
rather
due
omiss
sampl
assay
membran
incub
min
blot
solut
contain
nonfat
milk
powder
rins
min
phosphatebuff
salin
contain
tween
subsequ
membran
left
dri
room
temperatur
min
prior
cut
strip
store
use
western
immunoblot
assay
analysi
western
immunoblot
assay
carri
room
temperatur
rock
platform
incub
step
test
membran
strip
place
autoblot
incub
tray
genelab
diagnost
soak
min
ml
per
strip
mm
tri
buffer
tween
buffer
aspir
membran
strip
incub
h
l
respect
sera
includ
posit
neg
control
ml
block
buffer
contain
dri
milk
powder
membran
strip
wash
three
time
ml
wash
buffer
per
strip
allow
soak
wash
aspir
sera
membran
strip
incub
h
ml
conjug
goat
antihuman
igg
label
alkalin
phosphatas
kirkegaard
perri
laboratori
inc
gaithersburg
md
dilut
block
buffer
incub
conjug
remov
aspir
membran
strip
wash
anoth
three
time
follow
incub
membran
strip
substrat
solut
bcip
nitroblu
tetrazolium
result
protein
band
analyz
subject
intens
band
strip
assay
mous
rabbit
antisera
specif
dilut
use
antiserum
due
differ
titer
particular
dilut
use
mous
anti
antiserum
rabbit
anti
antiserum
wherea
dilut
use
mous
antim
antiserum
dilut
mous
antin
antiserum
howev
conjug
either
antimous
antirabbit
antibodi
label
alkalin
phosphatas
employ
detect
respect
antisera
use
dilut
ie
western
immunoblot
analysi
appar
molecular
mass
immunoreact
protein
estim
extrapol
plot
logarithm
molecular
mass
versu
electrophoret
mobil
standard
protein
immunoreact
protein
seen
band
immunoblot
assay
two
strong
sarsposit
control
sampl
includ
discreet
diffus
cluster
protein
approxim
kda
kda
triplet
kda
kda
doublet
kda
triplet
kda
diffus
fig
immunoblot
test
mous
rabbit
antisera
rais
specif
recombin
protein
protein
found
associ
n
protein
respect
fig
addit
protein
reactiv
strong
sarsposit
sampl
associ
e
protein
also
locat
approxim
kda
rabbit
anti
antiserum
fig
perform
variou
protein
marker
western
immunoblot
immunoblot
test
differ
set
specimen
sar
patient
healthi
donor
nonsar
patient
control
distinct
band
pattern
specif
sampl
sar
patient
control
observ
fig
analysi
band
pattern
show
two
protein
band
design
n
high
n
low
approxim
kda
associ
n
protein
sarscov
occur
often
react
sampl
sar
patient
tabl
howev
although
band
intens
two
protein
much
higher
sampl
sar
patient
n
high
n
low
rather
nonspecif
also
react
sampl
healthi
diseas
control
fig
tabl
exampl
n
high
protein
crossreact
sampl
healthi
donor
respiratori
ill
patient
fever
patient
control
respect
tabl
fact
nrelat
tabl
contrast
n
recombin
protein
react
sampl
sar
patient
without
crossreact
control
includ
identifi
fals
posit
elisa
tabl
highli
immunoreact
protein
includ
protein
react
respect
sampl
sar
patient
control
crossreact
rate
tabl
furthermor
protein
reactiv
portion
test
sampl
rather
nondiscriminatori
regardless
whether
sampl
sar
patient
healthi
diseas
control
tabl
e
protein
identifi
rabbit
antisera
hand
show
immunoreact
human
serum
sampl
test
studi
tabl
analysi
band
pattern
immunoreact
protein
reveal
use
criteria
differenti
sampl
sar
patient
control
simultan
detect
n
protein
n
high
n
low
protein
set
prerequisit
test
result
interpret
posit
sar
immunoblot
assay
found
sensit
specif
four
control
group
tabl
similarli
n
protein
n
high
n
low
consid
gstn
protein
immunoblot
assay
found
sensit
respect
maintain
specif
tabl
e
protein
howev
less
use
combin
due
lack
sensit
tabl
combin
interpret
criterion
util
n
protein
least
one
specif
protein
includ
protein
provid
kit
sensit
specif
tabl
addit
gstn
recombin
protein
interpret
criteria
improv
sensit
without
alter
specif
tabl
serolog
test
sar
whether
elisa
immunochromatograph
test
previous
report
either
sensit
specif
issu
addit
although
good
correl
exist
new
serolog
test
immunofluoresc
test
discrep
among
differ
approach
also
observ
previou
studi
henc
critic
resolv
discrep
identifi
potenti
falseposit
result
confirm
true
result
effect
manag
sar
differ
protein
marker
present
separ
western
immunoblot
thu
provid
array
inform
serolog
ap
proach
lack
need
precis
serolog
differenti
confirm
present
studi
reveal
util
sever
protein
indic
purpos
confirmatori
serodiagnosi
sar
includ
immunoreact
protein
kda
comparison
studi
protein
suggest
protein
associ
respect
n
protein
molecular
mass
similar
predict
genom
sequenc
novel
sarscov
ident
protein
verifi
specif
reactiv
respect
mous
rabbit
antisera
howev
triplet
present
approxim
kda
immunoblot
appear
novel
protein
predict
genom
sequenc
hand
appear
anoth
triplet
approxim
kda
consist
find
previou
report
uniqu
protein
use
specif
rabbit
antiserum
previou
studi
report
three
protein
band
design
western
blot
similar
region
kda
n
protein
sarscov
report
use
marker
serodiagnosi
sever
kit
report
util
protein
either
lysat
form
recombin
counterpart
antigen
howev
studi
confirm
util
immunoreact
marker
also
reveal
nonspecif
natur
protein
lysat
form
particular
two
protein
band
present
immunoblot
two
form
n
protein
sarscov
found
equal
immunoreact
n
high
n
low
react
sarsrel
sampl
well
fair
portion
sampl
healthi
donor
diseas
control
group
tabl
fact
protein
react
sampl
identifi
fals
posit
popul
healthi
donor
unit
state
sarsspecif
elisa
previou
studi
view
find
perhap
noteworthi
genom
sequenc
n
protein
natur
form
predict
highli
conserv
motif
found
cov
thu
surpris
viral
lysatederiv
n
protein
western
immunoblot
present
crossreact
nonsarsrel
sampl
result
consist
find
recent
report
antibodi
crossreact
human
anim
sarscov
sampl
healthi
adult
collect
year
prior
sar
outbreak
although
report
suggest
exist
sarsrel
viru
predat
sar
outbreak
possibl
observ
crossreact
due
distant
covrel
agent
complet
rule
view
present
find
respect
studi
sampl
new
western
blot
analysi
may
provid
use
inform
thu
warrant
investig
interestingli
find
also
echo
recent
report
crossreact
n
protein
sarscov
antigen
group
anim
cov
perhap
also
noteworthi
crossreact
could
theori
elimin
reduc
amount
n
protein
use
product
immunoblot
sinc
consist
differ
protein
band
intens
sar
sampl
control
fig
howev
impractic
product
immunoblot
manipul
amount
n
protein
without
affect
protein
lysat
mixtur
alreadi
produc
weaker
band
intens
immunoblot
fig
furthermor
result
studi
mous
rabbit
antisera
seem
suggest
high
intens
n
protein
might
due
highli
immunogen
natur
protein
rather
amount
use
product
immunoblot
among
three
specif
antisera
rais
n
protein
mice
antin
serum
highest
titer
antiserum
use
dilut
assay
produc
band
intens
anti
serum
dilut
fig
nevertheless
n
protein
western
immunoblot
use
indic
provid
use
combin
immunoreact
protein
aspect
although
protein
found
less
sensit
individu
critic
indic
combin
produc
sensit
without
compromis
specif
introduct
gstn
recombin
protein
criterion
protein
appear
synergist
necessari
perform
result
interpret
immunoblot
recombin
protein
contain
delet
conserv
motif
found
cov
may
explain
lower
crossreact
fulllength
counterpart
express
infect
cell
discuss
gstn
protein
use
interpret
criterion
combin
abovement
critic
protein
yield
kit
capabl
differenti
confirm
sampl
sar
patient
healthi
diseas
control
excel
sensit
specif
test
popul
tabl
consequ
select
criterion
marker
includ
lysat
n
protein
also
gstn
protein
result
test
new
western
immunoblot
consid
posit
lysat
n
protein
least
one
criterion
protein
detect
simultan
prerequisit
multipl
marker
combin
limit
possibl
impact
crossreact
n
protein
observ
elsewher
without
compromis
sensit
immunoblot
thu
provid
advantag
current
avail
test
reli
singl
n
protein
thank
hoe
nam
leong
yee
sin
leo
ai
ee
ling
provid
sar
patient
sera
project
partial
support
edb
econom
develop
board
singapor
grant
innov
develop
scheme
combin
test
result
consid
posit
nucleocapsid
n
high
n
low
least
one
lysat
criterion
protein
ie
detect
simultan
combin
test
result
consid
posit
nucleocapsid
n
high
n
low
least
one
lysat
criterion
protein
gstn
recombin
protein
detect
simultan
valu
percentag
